SAREPTA THERAPEUTICS, INC. Investment Income, Net
SAREPTA THERAPEUTICS, INC. (SRPT) reported Investment Income, Net of $63.00 thousand for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2013-11-12
- SAREPTA THERAPEUTICS, INC. investment income, net for the quarter ending 2013-09-30 was $63.00K, a 5.97% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. investment income, net for the quarter ending 2013-06-30 was -$19.00K, a 117.76% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. investment income, net for the quarter ending 2012-09-30 was $67.00K.
- SAREPTA THERAPEUTICS, INC. investment income, net for the quarter ending 2012-06-30 was $107.00K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 395 month | Investment Income, Net 398 month |
|---|---|---|---|---|---|
| 2013-09-30 | $63.00K 10-Q · filed 2013-11-12 | $44.00K derived: sum of 2 quarters · filed 2013-11-12 | $281.00K 10-Q · filed 2013-11-12 | $9.80M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | -$19.00K 10-Q · filed 2013-08-08 | $218.00K 10-Q · filed 2013-08-08 | $9.74M 10-Q · filed 2013-08-08 | ||
| 2012-09-30 | $67.00K 10-Q · filed 2013-11-12 | $174.00K derived: sum of 2 quarters · filed 2013-11-12 | $270.00K 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | $107.00K 10-Q · filed 2013-08-08 | $203.00K 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |